Contemplating a Science Court:

The past two decades have seen much discussion among legal and science professionals about the competence with which our elected officials decide upon public policy matters that have a scientific or technological dimension. A consensus seems to have formed that the present system of decision making is flawed, that policymakers lack the expertise to weigh complex technical data, and that scientific facts are too often mangled in the political arena, thus rendering rational decisions nearly imposs

Written byEugene Garfield
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Arthur Kantrowitz has been an articulate proponent of creating a science court designed to improve such decision making. The court would weigh scientific data pertaining to an issue apart from its political and moral considerations. As a current example, the Reagan administration's SDI program is a controversial public policy issue with an obvious scientific and technological dimension. Just as clearly, it has political and moral dimensions. A science court might be asked to render a judgment on the technical feasibility of deploying a shield in space that would guard against incoming ballistic missiles and its economic costs relative to other technical options for achieving the same ends. In this and all other matters put to it, the court would leave aside political and moral questions, such as, should a space shield be deployed?

Central to the concept of a science court is a belief in the utility of separating the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies